Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 2001 Jul;85(1):122–128. doi: 10.1054/bjoc.2001.1862

Low-dose retinoic acid enhances in vitro invasiveness of human oral squamous-cell-carcinoma cell lines

D Uchida 1, H Kawamata 2, K Nakashiro 1, F Omotehara 1, S Hino 1, M O Hoque 1, N-M Begum 1, H Yoshida 1, M Sato 1, T Fujimori 2
PMCID: PMC2363904  PMID: 11437413

Abstract

Retinoids inhibit the proliferation of several types of tumour cells, and are used for patients with several malignant tumours. In this study, we examined the effect of retinoic acids (RAs) on the invasive potentials of the oral squamous cell carcinoma (SCC) cells, BHY and HNt. BHY cells expressed all of retinoid nuclear receptors (RARα, β, γ, and RXRα) and cytoplasmic retinoic acid binding proteins (CRABP1 and CRABP2). HNt cells lacked the expression of RARβ, but expressed other nuclear receptors and CRABPs. All-trans retinoic acid (ATRA) and 13-cis retinoic acid (13-cisRA) (10−6and 10−7M) inhibited the growth of the cells, but low-dose ATRA and 13-cisRA (10−8M) marginally affected the growth of the cells. Surprisingly, low-dose RAs enhanced the activity of tissue-type plasminogen activator (tPA), and activated pro-matrix metalloproteinases (proMMP2 and proMMP9). Activation of proMMP2 and proMMP9 was inhibited by aprotinin, a serine-proteinase, tPA inhibitor. Furthermore, low-dose RAs enhanced the in vitro invasiveness of BHY cells. These results indicate that low-dose RAs enhances the in vitro invasiveness of oral SCC cells via an activation of proMMP2 and proMMP9 probably mediated by the induction of tPA. © 2001 Cancer Research Campaign http://www.bjcancer.com

Keywords: oral squamous cell carcinoma, retinoic acid, invasion, tPA, MMP

Full Text

The Full Text of this article is available as a PDF (140.0 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Baramova E. N., Bajou K., Remacle A., L'Hoir C., Krell H. W., Weidle U. H., Noel A., Foidart J. M. Involvement of PA/plasmin system in the processing of pro-MMP-9 and in the second step of pro-MMP-2 activation. FEBS Lett. 1997 Mar 24;405(2):157–162. doi: 10.1016/s0014-5793(97)00175-0. [DOI] [PubMed] [Google Scholar]
  2. Bracke M. E., Van Larebeke N. A., Vyncke B. M., Mareel M. M. Retinoic acid modulates both invasion and plasma membrane ruffling of MCF-7 human mammary carcinoma cells in vitro. Br J Cancer. 1991 Jun;63(6):867–872. doi: 10.1038/bjc.1991.191. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Bulens F., Merchiers P., Ibañez-Tallon I., De Vriese A., Nelles L., Claessens F., Belayew A., Collen D. Identification of a multihormone responsive enhancer far upstream from the human tissue-type plasminogen activator gene. J Biol Chem. 1997 Jan 3;272(1):663–671. doi: 10.1074/jbc.272.1.663. [DOI] [PubMed] [Google Scholar]
  4. Carmichael J., DeGraff W. G., Gazdar A. F., Minna J. D., Mitchell J. B. Evaluation of a tetrazolium-based semiautomated colorimetric assay: assessment of chemosensitivity testing. Cancer Res. 1987 Feb 15;47(4):936–942. [PubMed] [Google Scholar]
  5. He L. Z., Merghoub T., Pandolfi P. P. In vivo analysis of the molecular pathogenesis of acute promyelocytic leukemia in the mouse and its therapeutic implications. Oncogene. 1999 Sep 20;18(38):5278–5292. doi: 10.1038/sj.onc.1203088. [DOI] [PubMed] [Google Scholar]
  6. Hendrix M. J., Wood W. R., Seftor E. A., Lotan D., Nakajima M., Misiorowski R. L., Seftor R. E., Stetler-Stevenson W. G., Bevacqua S. J., Liotta L. A. Retinoic acid inhibition of human melanoma cell invasion through a reconstituted basement membrane and its relation to decreases in the expression of proteolytic enzymes and motility factor receptor. Cancer Res. 1990 Jul 1;50(13):4121–4130. [PubMed] [Google Scholar]
  7. Hong W. K., Lippman S. M., Itri L. M., Karp D. D., Lee J. S., Byers R. M., Schantz S. P., Kramer A. M., Lotan R., Peters L. J. Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990 Sep 20;323(12):795–801. doi: 10.1056/NEJM199009203231205. [DOI] [PubMed] [Google Scholar]
  8. Imai S., Okuno M., Moriwaki H., Muto Y., Murakami K., Shudo K., Suzuki Y., Kojima S. 9,13-di-cis-Retinoic acid induces the production of tPA and activation of latent TGF-beta via RAR alpha in a human liver stellate cell line, LI90. FEBS Lett. 1997 Jul 7;411(1):102–106. doi: 10.1016/s0014-5793(97)00673-x. [DOI] [PubMed] [Google Scholar]
  9. Jetten A. M., Kim J. S., Sacks P. G., Rearick J. I., Lotan D., Hong W. K., Lotan R. Inhibition of growth and squamous-cell differentiation markers in cultured human head and neck squamous carcinoma cells by beta-all-trans retinoic acid. Int J Cancer. 1990 Jan 15;45(1):195–202. doi: 10.1002/ijc.2910450135. [DOI] [PubMed] [Google Scholar]
  10. Kawamata H., Nakashiro K., Uchida D., Harada K., Yoshida H., Sato M. Possible contribution of active MMP2 to lymph-node metastasis and secreted cathepsin L to bone invasion of newly established human oral-squamous-cancer cell lines. Int J Cancer. 1997 Jan 6;70(1):120–127. doi: 10.1002/(sici)1097-0215(19970106)70:1<120::aid-ijc18>3.0.co;2-p. [DOI] [PubMed] [Google Scholar]
  11. Kawamata H., Uchida D., Hamano H., Kimura-Yanagawa T., Nakashiro K. I., Hino S., Omotehara F., Yoshida H., Sato M. Active-MMP2 in cancer cell nests of oral cancer patients: correlation with lymph node metastasis. Int J Oncol. 1998 Oct;13(4):699–704. [PubMed] [Google Scholar]
  12. Komiyama S., Hiroto I., Ryu S., Nakashima T., Kuwano M., Endo H. Synergistic combination therapy of 5-fluorouracil, vitamin A and cobalt-60 radiation upon head and neck tumors. Oncology. 1978;35(6):253–257. doi: 10.1159/000225299. [DOI] [PubMed] [Google Scholar]
  13. Lansink M., Koolwijk P., van Hinsbergh V., Kooistra T. Effect of steroid hormones and retinoids on the formation of capillary-like tubular structures of human microvascular endothelial cells in fibrin matrices is related to urokinase expression. Blood. 1998 Aug 1;92(3):927–938. [PubMed] [Google Scholar]
  14. Lippman S. M., Glisson B. S., Kavanagh J. J., Lotan R., Hong W. K., Paredes-Espinoza M., Hittelman W. N., Holdener E. E., Krakoff I. H. Retinoic acid and interferon combination studies in human cancer. Eur J Cancer. 1993;29A Suppl 5:S9–13. doi: 10.1016/0959-8049(93)90618-p. [DOI] [PubMed] [Google Scholar]
  15. Lo Coco F., Nervi C., Avvisati G., Mandelli F. Acute promyelocytic leukemia: a curable disease. Leukemia. 1998 Dec;12(12):1866–1880. doi: 10.1038/sj.leu.2401230. [DOI] [PubMed] [Google Scholar]
  16. Lotan R., Dawson M. I., Zou C. C., Jong L., Lotan D., Zou C. P. Enhanced efficacy of combinations of retinoic acid- and retinoid X receptor-selective retinoids and alpha-interferon in inhibition of cervical carcinoma cell proliferation. Cancer Res. 1995 Jan 15;55(2):232–236. [PubMed] [Google Scholar]
  17. Lotan R. Retinoids and chemoprevention of aerodigestive tract cancers. Cancer Metastasis Rev. 1997 Sep-Dec;16(3-4):349–356. doi: 10.1023/a:1005808429176. [DOI] [PubMed] [Google Scholar]
  18. Lotan R. Suppression of squamous cell carcinoma growth and differentiation by retinoids. Cancer Res. 1994 Apr 1;54(7 Suppl):1987s–1990s. [PubMed] [Google Scholar]
  19. Mars W. M., Zarnegar R., Michalopoulos G. K. Activation of hepatocyte growth factor by the plasminogen activators uPA and tPA. Am J Pathol. 1993 Sep;143(3):949–958. [PMC free article] [PubMed] [Google Scholar]
  20. Mitchell M. F., Hittelman W. K., Lotan R., Nishioka K., Tortolero-Luna G., Richards-Kortum R., Wharton J. T., Hong W. K. Chemoprevention trials and surrogate end point biomarkers in the cervix. Cancer. 1995 Nov 15;76(10 Suppl):1956–1977. doi: 10.1002/1097-0142(19951115)76:10+<1956::aid-cncr2820761312>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
  21. Oridate N., Lotan D., Xu X. C., Hong W. K., Lotan R. Differential induction of apoptosis by all-trans-retinoic acid and N-(4-hydroxyphenyl)retinamide in human head and neck squamous cell carcinoma cell lines. Clin Cancer Res. 1996 May;2(5):855–863. [PubMed] [Google Scholar]
  22. Oridate N., Suzuki S., Higuchi M., Mitchell M. F., Hong W. K., Lotan R. Involvement of reactive oxygen species in N-(4-hydroxyphenyl)retinamide-induced apoptosis in cervical carcinoma cells. J Natl Cancer Inst. 1997 Aug 20;89(16):1191–1198. doi: 10.1093/jnci/89.16.1191. [DOI] [PubMed] [Google Scholar]
  23. Pemrick S. M., Lucas D. A., Grippo J. F. The retinoid receptors. Leukemia. 1994 Nov;8(11):1797–1806. [PubMed] [Google Scholar]
  24. Sun S. Y., Li W., Yue P., Lippman S. M., Hong W. K., Lotan R. Mediation of N-(4-hydoxyphenyl)retinamide-induced apoptosis in human cancer cells by different mechanisms. Cancer Res. 1999 May 15;59(10):2493–2498. [PubMed] [Google Scholar]
  25. Sun S. Y., Yue P., Lotan R. Induction of apoptosis by N-(4-hydroxyphenyl)retinamide and its association with reactive oxygen species, nuclear retinoic acid receptors, and apoptosis-related genes in human prostate carcinoma cells. Mol Pharmacol. 1999 Mar;55(3):403–410. [PubMed] [Google Scholar]
  26. Sun S. Y., Yue P., Wu G. S., El-Deiry W. S., Shroot B., Hong W. K., Lotan R. Mechanisms of apoptosis induced by the synthetic retinoid CD437 in human non-small cell lung carcinoma cells. Oncogene. 1999 Apr 8;18(14):2357–2365. doi: 10.1038/sj.onc.1202543. [DOI] [PubMed] [Google Scholar]
  27. Tiberio A., Farina A. R., Tacconelli A., Cappabianca L., Gulino A., Mackay A. R. Retinoic acid-enhanced invasion through reconstituted basement membrane by human SK-N-SH neuroblastoma cells involves membrane-associated tissue-type plasminogen activator. Int J Cancer. 1997 Nov 27;73(5):740–748. doi: 10.1002/(sici)1097-0215(19971127)73:5<740::aid-ijc22>3.0.co;2-8. [DOI] [PubMed] [Google Scholar]
  28. Vermeulen S. J., Bruyneel E. A., van Roy F. M., Mareel M. M., Bracke M. E. Activation of the E-cadherin/catenin complex in human MCF-7 breast cancer cells by all-trans-retinoic acid. Br J Cancer. 1995 Dec;72(6):1447–1453. doi: 10.1038/bjc.1995.528. [DOI] [PMC free article] [PubMed] [Google Scholar]
  29. Wan H., Oridate N., Lotan D., Hong W. K., Lotan R. Overexpression of retinoic acid receptor beta in head and neck squamous cell carcinoma cells increases their sensitivity to retinoid-induced suppression of squamous differentiation by retinoids. Cancer Res. 1999 Jul 15;59(14):3518–3526. [PubMed] [Google Scholar]
  30. Webber M. M., Waghray A. Urokinase-mediated extracellular matrix degradation by human prostatic carcinoma cells and its inhibition by retinoic acid. Clin Cancer Res. 1995 Jul;1(7):755–761. [PubMed] [Google Scholar]
  31. Wood W. R., Seftor E. A., Lotan D., Nakajima M., Misiorowski R. L., Seftor R. E., Lotan R., Hendrix M. J. Retinoic acid inhibits human melanoma tumor cell invasion. Anticancer Res. 1990 Mar-Apr;10(2A):423–432. [PubMed] [Google Scholar]
  32. Xu X. C., Liu X., Tahara E., Lippman S. M., Lotan R. Expression and up-regulation of retinoic acid receptor-beta is associated with retinoid sensitivity and colony formation in esophageal cancer cell lines. Cancer Res. 1999 May 15;59(10):2477–2483. [PubMed] [Google Scholar]
  33. Yamamoto H., Itoh F., Hinoda Y., Imai K. Suppression of matrilysin inhibits colon cancer cell invasion in vitro. Int J Cancer. 1995 Apr 10;61(2):218–222. doi: 10.1002/ijc.2910610213. [DOI] [PubMed] [Google Scholar]
  34. Zou C. P., Kurie J. M., Lotan D., Zou C. C., Hong W. K., Lotan R. Higher potency of N-(4-hydroxyphenyl)retinamide than all-trans-retinoic acid in induction of apoptosis in non-small cell lung cancer cell lines. Clin Cancer Res. 1998 May;4(5):1345–1355. [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES